StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the stock.
China Pharma Stock Performance
China Pharma stock opened at $0.25 on Thursday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.25 and a current ratio of 0.89. China Pharma has a 52-week low of $0.24 and a 52-week high of $1.77. The firm has a 50 day moving average price of $0.27 and a two-hundred day moving average price of $0.35.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The firm had revenue of $1.37 million for the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Ride Out The Recession With These Dividend Kings
- Why Call Options Volume for These 2 Stocks Spiked Together
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
